EP 0048280 A1 19820331 - SKIN AND NAIL COMPOSITION CONTAINING PHOSPHATE-TRIALKANOLAMINE COMPLEX.
Title (en)
SKIN AND NAIL COMPOSITION CONTAINING PHOSPHATE-TRIALKANOLAMINE COMPLEX.
Title (de)
PHOSPHAT-TRIALKANOLAMIN-KOMPLEXE ENTHALTENDE ZUSAMMENSETZUNG FÜR DIE HAUT UND NÄGEL.
Title (fr)
COMPOSITION POUR LA PEAU ET LES ONGLES CONTENANT UN COMPLEXE DE PHOSPHATE-TRIALCANOLAMINE.
Publication
Application
Priority
CA 348458 A 19800326
Abstract (en)
[origin: WO8102673A1] Topical medicaments and skin and nail preparations which comprise a phosphatide component (a) and an ethanolamine component (b). In the skin and nail embodiments there is no necessity for any additional third component, although additional ingredients may be included. In the topical medicament embodiment, there are three components, the invention as to topical medicaments being a preparation for application to the skin of a patient which contains a drug capable of passing through said skin to provide topical relief to said patient for the purpose for which said drug is administered, said topical medicament comprising a mixture of: (a) at least about 1% by weight of a lecithin-containing phosphatide, the amount of lecithin in said phosphatide being about 10% to about 40% by weight; (b) at least about 0-2% by weight triethanolamine; and (c) a drug suitable for topical administration, said topical medicament providing said drug suitable for topical administration in a form to permit retention of said drug at the skin of said patient to whom said drug being applied and protecting the skin area due to the presence of a complex of the components (a) and (b).
Abstract (fr)
Des medicaments topiques et des preparations pour la peau et les ongles comprennent un composant phosphatide (a) et un composant ethanolamine (b). Dans les preparations pour la peau et les ongles il n'est pas necessaire d'ajouter un troisieme composant, bien que des ingredients supplementaires puissent etre inclus. Dans le medicament topique, il y a trois composants, l'invention concernant les medicaments topiques etant une preparation d'application sur la peau d'un patient, qui contient un medicament pouvant traverser la peau pour produire un effet de soulagement topique, ce medicament topique comprenant un melange de: (a) au moins environ 1% en poids d'un phosphatide contenant de la lecithine, la quantite de lecithine dans le phosphatide etant d'environ 10% a environ 40% en poids; (b) au moins environ 0,2% en poids de triethanolamine; et (c) un medicament approprie a l'usage local du medicament topique sous une forme permettant la retention du medicament sur la peau du patient et protegeant la peau grace a la presence d'un complexe des composants (a) et (b).
IPC 1-7
IPC 8 full level
A61K 8/41 (2006.01); A61K 8/55 (2006.01); A61K 8/63 (2006.01); A61K 47/18 (2006.01); A61K 47/24 (2006.01); A61Q 19/00 (2006.01)
CPC (source: EP)
A61K 8/41 (2013.01); A61K 8/553 (2013.01); A61K 8/63 (2013.01); A61K 9/0014 (2013.01); A61K 47/18 (2013.01); A61K 47/24 (2013.01); A61Q 19/00 (2013.01); A61Q 3/00 (2013.01)
Designated contracting state (EPC)
CH DE FR GB LI NL SE
DOCDB simple family (publication)
WO 8102673 A1 19811001; CA 1134276 A 19821026; EP 0048280 A1 19820331
DOCDB simple family (application)
US 8100411 W 19810326; CA 348458 A 19800326; EP 81901083 A 19810326